World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, Scholar Article Journal Index (SAJI), International Scientific Indexing ( ISI ), 



Mizba Bushra Khanam* and Dr. J. Raghu Ram


Aim: The present study is focused mainly to assess the existing drug therapies and procedures with appropriate amount and administrating time use of antibiotic prophylaxis to prevent urinary tract infection and bacteremia (sepsis) following endoscopic urologic procedures. Objective: Evidence in the literature revealed that urological instrumentation is associated with increased incidence of urinary tract infection and bacteremia. The objective of this research is to evaluate the effectiveness of antibiotic prophylaxis in reducing the risk of urinary tract infection in patients who had undergone urological surgeries. For common urological disorders, open surgery has largely been replaced by cystoscopy with access through the urinary tract and laparoscopic surgery. Methodology: A systematic protocol is conducted to compare the different drug therapies and timing of administration of antibiotic prophylaxis in patients undergoing urological surgery. We had use predefined inclusion and exclusion criteria, and also develop a specific quality scale to assess the quality of the research. Result: Antibiotic therapy should be used for patients who are going to undergo urological surgery due to a 60% risk of presenting with infectious complications such as bacteraemia and a 10% risk of sepsis. Some clinical trials have shown that antibiotic prophylaxis in patients decreases the risk of bacteraemia and sepsis in the postoperative period, but there is no general agreement on the treatment type or when to start antibiotic therapy. 28 of 49 (57.14%) patients undergoing laparoscopic radical prostatectomy received prophylaxis preoperative, 11 of 49 (22.44%) patients received prophylaxis postoperatively, and one received none for the same procedure. Studies should start prophylaxis between 1 to 7 days before the procedure, with determining the differences in the results for each intervention. Evidence in the literature revealed that urological instrumentation is associated with increased incidence of urinary tract infection and bacteremia. Potential sources of bacteria leading to infection include the prostatic adenoma, urethral flora, bladder colonization, or perioperative contamination.

[Full Text Article]


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here